(Q33160239)

English

Effectiveness of midodrine treatment in patients with recurrent vasovagal syncope not responding to non-pharmacological treatment (STAND-trial).

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

23 July 2017

Effectiveness of midodrine treatment in patients with recurrent vasovagal syncope not responding to non-pharmacological treatment (STAND-trial). (English)

1 reference

Europe PubMed Central

23 July 2017

0 references

vasovagal response

0 references

1 reference

based on heuristic

inferred from title

2

0 references

5

0 references

Johannes B Reitsma

4

object named as

Johannes B Reitsma

1 reference

Europe PubMed Central

23 July 2017

author name string

Jacobus J C M Romme

1

1 reference

Europe PubMed Central

23 July 2017

Ingeborg K Go-Schön

3

1 reference

Europe PubMed Central

23 July 2017

publication date

13 July 2011

1 reference

Europe PubMed Central

23 July 2017

1 reference

Europe PubMed Central

23 July 2017

13

1 reference

Europe PubMed Central

23 July 2017

11

1 reference

Europe PubMed Central

23 July 2017

1639-1647

1 reference

Europe PubMed Central

23 July 2017

Guidelines for the diagnosis and management of syncope (version 2009)

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR200

21 January 2018

Syncope: therapeutic approaches

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR200

21 January 2018

Nonpharmacological treatment of reflex syncope

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR200

21 January 2018

Effectiveness of physical counterpressure maneuvers in preventing vasovagal syncope: the Physical Counterpressure Manoeuvres Trial (PC-Trial).

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR200

21 January 2018

Pharmacological treatment of reflex syncope

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR200

21 January 2018

Evidence-based treatment for vasovagal syncope

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR200

21 January 2018

Midodrine in neurally mediated syncope: a double-blind, randomized, crossover study

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR200

21 January 2018

alpha-Adrenoceptor agonists for the treatment of vasovagal syncope: a meta-analysis of worldwide published data

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR200

21 January 2018

The efficacy of midodrine hydrochloride in the treatment of children with vasovagal syncope

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR200

21 January 2018

Usefulness of midodrine in patients with severely symptomatic neurocardiogenic syncope: a randomized control study

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR200

21 January 2018

Prospective evaluation of non-pharmacological treatment in vasovagal syncope

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR200

21 January 2018

Transient loss of consciousness: the value of the history for distinguishing seizure from syncope

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR200

21 January 2018

Guidelines on management (diagnosis and treatment) of syncope--update 2004.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR200

21 January 2018

Midodrine. A review of its therapeutic use in the management of orthostatic hypotension

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR200

21 January 2018

Clinical factors associated with quality of life in patients with transient loss of consciousness

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR200

21 January 2018

Translation, validation, and norming of the Dutch language version of the SF-36 Health Survey in community and chronic disease populations.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR200

21 January 2018

Recurrent syncope as a chronic disease: preliminary validation of a disease-specific measure of functional impairment

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR200

21 January 2018

Reliability, validity and responsiveness of the syncope functional status questionnaire

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR200

21 January 2018

Risk factors for syncope recurrence after a positive tilt-table test in patients with syncope

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR200

21 January 2018

Improved confidence intervals for the difference between binomial proportions based on paired data

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR200

21 January 2018

Problems with the two stage analysis of crossover trials [letter; comment]

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR200

21 January 2018

Preliminary observations on the use of midodrine hydrochloride in the treatment of refractory neurocardiogenic syncope

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR200

21 January 2018

Prospective evaluation of a two-step therapeutic strategy in neurocardiogenic syncope: midodrine as second line treatment in patients refractory to beta-blockers

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR200

21 January 2018

Midodrine hydrochloride in the treatment of vasovagal syncope.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR200

21 January 2018

Influence of pravastatin on lipoproteins, and on endothelial, platelet, and inflammatory markers in subjects with peripheral artery disease

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR200

21 January 2018

Efficacy of midodrine hydrochloride in neurocardiogenic syncope refractory to standard therapy

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR200

21 January 2018

Prospective evaluation of psychological distress and psychiatric morbidity in recurrent vasovagal and unexplained syncope

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR200

21 January 2018

The role of psychological factors in response to treatment in neurocardiogenic (vasovagal) syncope

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR200

21 January 2018

Worsening of symptoms before presentation with vasovagal syncope

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR200

21 January 2018

Prospective evaluation of day-to-day reproducibility of upright tilt-table testing in unexplained syncope

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR200

21 January 2018

Reproducibility of isoproterenol tilt-table tests in patients with syncope

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR200

21 January 2018

Limitations of head-up tilt test for evaluating the efficacy of therapeutic interventions in patients with vasovagal syncope: results of a controlled study of etilefrine versus placebo.

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR200

21 January 2018

Predictors of patient-assessed illness severity in irritable bowel syndrome

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR200

21 January 2018

Pharmacokinetic and pharmacodynamic effects of midodrine on blood pressure, the autonomic nervous system, and plasma natriuretic peptides: a prospective, randomized, single-blind, two-period, crossover, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1093%2FEUROPACE%2FEUR200

21 January 2018

Identifiers

10.1093/EUROPACE/EUR200

1 reference

Europe PubMed Central

23 July 2017

1 reference

Europe PubMed Central

23 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33160239&oldid=1973870169"